The document summarizes Malaysia's efforts to promote clinical trials and establish itself as a regional clinical research hub. It outlines the Clinical Research Centre (CRC) as a one-stop center that can facilitate all aspects of conducting clinical trials in Malaysia, including providing investigator networks, regulatory and ethics submissions, data management, and other support services. CRC aims to make the clinical trials process efficient and help sponsors conduct trials in Malaysia. The document also highlights Malaysia's competitive advantages for clinical research such as its supportive government policies, qualified researchers, diverse patient populations, and lower costs.

1. Promoting Malaysia as a Trial Hub, CRC as One-Stop-Center Ong Loke Meng 24 September 2007

5. Malaysia welcomes you

6. Clinical Trials in Malaysia Note These statistics are based on the number of applications received by National Pharmaceutical Control Bureau for the clinical trial import license for unregistered products. Drug-related clinical trials for registered products which do not require clinical trial import license is not controlled by the Drug Control Authority.

7. Number of CT Applications by Therapeutic Class 1998-2005 8 IMMUNOLOGICAL PRODUCTS & VACCINES 8 DRUGS AFFECTING BONE METABOLISM 10 FOOD SUPPLEMENT/TRADITIONAL MEDICINE 11 MUSCULOSKELETAL & JOINT DISEASE 12 GASTROINTESTINAL SYSTEMS 12 DRUGS FOR GENITO-URINARY DISORDERS 14 LIPID LOWERING DRUGS 19 RESPIRATORY SYSTEM 19 ANTIBACTERIAL DRUGS 24 ANAEMIAS & OTHER BLOOD DISORDERS 27 DRUGS USE IN PSYCHOSES 33 ANTIVIRAL DRUGS 36 CYTOTOXIC DRUGS 40 CARDIOVASCULAR SYSTEMS 49 DRUGS USED IN DIABETES # Therapeutic area

19. Thank You www.crc.gov.my